Skip to main content
Equibles
ADAPY $0.02 -19.64%
ADAPY logo
ADAPY · Adaptimmune Therapeutics PLC
Track ADAPY — free

Use ADAPY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.02 -0.01 (-19.64%) At close · Aug 31
Rebalance outlook locked
Market Cap
$35.94M
Shares
1.59B
All earnings calls

Earnings call · FY2023 Q1

Adaptimmune Therapeutics PLC (ADAPY) Q1 2023 Earnings Call

Concluded May 12, 2023
May 12, 2023 0 turns
Period
FY2023 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $47.60M +1231.5% YoY
Diluted EPS $0.00
Net income $1.04M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 12, 2023 10-Q report Filed May 12, 2023
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)